Key result
Statins provide cholesterol-independent vascular benefits by inhibiting isoprenoids and small GTP-binding proteins.
Answers are grounded in this paper and cite their sources.
This review summarizes the cholesterol-independent, pleiotropic effects of statins, such as improving endothelial function and reducing inflammation, which are mediated by the inhibition of isoprenoids and small GTP-binding proteins.
Statins are potent inhibitors of cholesterol biosynthesis. In clinical trials, statins are beneficial in the primary and secondary prevention of coronary heart disease. However, the overall benefits observed with statins appear to be greater than what might be expected from changes in lipid levels alone, suggesting effects beyond cholesterol lowering. Indeed, recent studies indicate that some of the cholesterol-independent or "pleiotropic" effects of statins involve improving endothelial function, enhancing the stability of atherosclerotic plaques, decreasing oxidative stress and inflammation, and inhibiting the thrombogenic response. Furthermore, statins have beneficial extrahepatic effects on the immune system, CNS, and bone. Many of these pleiotropic effects are mediated by inhibition of isoprenoids, which serve as lipid attachments for intracellular signaling molecules. In particular, inhibition of small GTP-binding proteins, Rho, Ras, and Rac, whose proper membrane localization and function are dependent on isoprenylation, may play an important role in mediating the pleiotropic effects of statins.
No takes yet. Share an insight, caveat, or question.
Liao et al. (2004) conducted a review in Coronary heart disease. Statins was evaluated. Statins exert cholesterol-independent pleiotropic effects—including improved endothelial function and plaque stability—mediated by inhibiting isoprenoids and small GTP-binding proteins.
Synapse has enriched 10 related papers. Consider them for comparative context: